Our Mission

Built to close the gap between diagnosis and disengagement.

LenZA exists because patients don't leave HIV and PrEP care loudly โ€” they just stop showing up, and the systems meant to notice often don't. We build the infrastructure that catches that moment early, at facility level, without requiring internet connectivity these programmes often can't rely on.

Team

Built by people who've done this work.

Mihir Patnaik

Mihir Patnaik

Founder & CEO

20 years of experience in software engineering, CRM platforms, and digital health solutions. Solo-built the entire LenZA platform โ€” product, engineering, and architecture โ€” while driving market development and strategic partnerships across sub-Saharan Africa.

Fatima Maha

Fatima Maha

Co-Founder, Commercial  ยท  LinkedIn

Leads LenZA's commercial strategy, driving business development, strategic partnerships, and market expansion across Africa. Works with implementing partners, healthcare organisations, and funders to connect LenZA with the programmes that need it.

Mbekuveh Dinga-Nyoh

Mbekuveh Dinga-Nyoh

Partner, Country Lead โ€” Cameroon  ยท  LinkedIn

Health systems professional with experience as a consultant for UNAIDS. Leads LenZA's market entry and country strategy in Cameroon, guiding clinical adaptation to ensure the platform fits local healthcare workflows and provider needs.

Momentum

Where LenZA stands today.

LenZA active countries: Nigeria, Cameroon, Uganda, Zambia, South Africa

Active pipeline and engagement across five countries, from a live pilot in Nigeria to partnership discussions in Cameroon, Uganda, Zambia, and South Africa.

Live Pilot โ€” Nigeria

Supporting real patient workflows in HIV and PrEP care since July 2026, including 137,000+ patient records imported in a single production-scale operation.

Clinical Validation

"Brilliant, long overdue, better than TIER.net." โ€” Principal Investigator, leading South African HIV research institution.

Cameroon Market Entry

Country Lead onboarded with a signed partnership agreement and a defined subscription-plus-implementation model.

Regional Presence

Active engagement across Nigeria, South Africa, Zambia, Cameroon, and Uganda โ€” spanning government programmes, implementing organisations, and research institutions.

Market Context

The timing problem this solves.

Lenacapavir Rollout

Six-monthly injectable PrEP is rolling out across 9+ African countries โ€” creating urgent need for long-cycle follow-up tracking that paper registers cannot handle.

PEPFAR Funding Transition

Existing digital health infrastructure is being disrupted โ€” facilities losing support systems need affordable, offline-capable alternatives.

Legacy Systems Ageing Out

South Africa's TIER.net is being phased out, and facilities across the continent face similar gaps with ageing, fragmented patient tracking systems that were never built for today's scale.

Global Fund Commitment

A commitment to reach 3 million people with injectable PrEP by 2028 โ€” programmes need tools to actually track them.

As injectable PrEP scales across Africa, the programmes delivering it need tools that track the complete patient journey โ€” from first contact to sustained treatment. That's what LenZA is built for.

Built For

Organisations delivering HIV & PrEP care at scale.

Implementing Partners

PEPFAR implementing partners and HIV programme delivery organisations.

Government Programmes

National and provincial government health programmes.

Research Institutions

Clinical research institutions conducting HIV and PrEP studies.

NGOs & Community Organisations

NGOs, community-based and faith-based organisations running HIV prevention and treatment.

Partner with us.

Whether you're evaluating LenZA for a facility rollout, a research collaboration, or an investment conversation โ€” we'd like to hear from you.